HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

teprotumumab

a fully human IgG1 type monoclonal antibody directed against the human insulin-like growth factor-I receptor
Also Known As:
R 1507; R-1507; R-1507 monoclonal antibody; R1507; RO-4858696; RO-4858696-000; RO-4858696000; RO4858696; RO4858696-000; RV-001; RV001; tepezza; teprotumumab-trbw
Networked: 178 relevant articles (38 outcomes, 36 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Douglas, Raymond S: 16 articles (01/2022 - 01/2017)
2. Smith, Terry J: 14 articles (01/2022 - 01/2017)
3. Ugradar, Shoaib: 12 articles (03/2022 - 01/2021)
4. Kahaly, George J: 11 articles (01/2022 - 01/2017)
5. Wang, Yao: 8 articles (01/2022 - 01/2019)
6. Douglas, Raymond: 7 articles (03/2022 - 09/2021)
7. Kossler, Andrea L: 7 articles (01/2022 - 05/2021)
8. Shriver, Erin M: 5 articles (07/2022 - 01/2017)
9. Cockerham, Kimberly: 5 articles (03/2022 - 09/2021)
10. Boerman, Otto C: 5 articles (09/2013 - 10/2010)

Related Diseases

1. Exophthalmos (Proptosis)
2. Diplopia (Double Vision)
3. Graves Ophthalmopathy
4. Inflammation (Inflammations)
5. Optic Nerve Diseases (Optic Neuropathy)

Related Drugs and Biologics

1. Insulin-Like Peptides
2. IGF Type 1 Receptor (IGF 1 Receptor)
3. Monoclonal Antibodies
4. tocilizumab (atlizumab)
5. Troleandomycin (TAO)
6. Rituximab (Mabthera)
7. Steroids
8. Somatomedin Receptors (Somatomedin Receptor)
9. Methylprednisolone
10. Prednisone (Sone)

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Intravenous Infusions
4. Retreatment
5. Thyroidectomy